Humana Inc. (NYSE:HUM) Stock Position Reduced by PFM Health Sciences LP

PFM Health Sciences LP lessened its position in shares of Humana Inc. (NYSE:HUM) by 18.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 101,954 shares of the insurance provider’s stock after selling 23,386 shares during the quarter. Humana comprises about 1.8% of PFM Health Sciences LP’s investment portfolio, making the stock its 21st largest position. PFM Health Sciences LP’s holdings in Humana were worth $32,293,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of HUM. Atria Investments Inc lifted its holdings in shares of Humana by 14.5% in the 1st quarter. Atria Investments Inc now owns 5,329 shares of the insurance provider’s stock worth $1,848,000 after purchasing an additional 673 shares during the last quarter. Cetera Investment Advisers lifted its holdings in shares of Humana by 249.0% in the 1st quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock worth $7,262,000 after purchasing an additional 14,944 shares during the last quarter. Cetera Advisors LLC lifted its holdings in shares of Humana by 472.1% in the 1st quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock worth $3,501,000 after purchasing an additional 8,333 shares during the last quarter. Kathmere Capital Management LLC bought a new stake in shares of Humana in the 2nd quarter worth approximately $170,000. Finally, Transcend Capital Advisors LLC bought a new stake in shares of Humana in the 2nd quarter worth approximately $433,000. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on HUM shares. Leerink Partners downgraded Humana from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $400.00 to $250.00 in a report on Wednesday, October 2nd. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Barclays lifted their target price on Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. UBS Group cut their target price on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 target price on shares of Humana in a research note on Tuesday, October 1st. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $315.86.

Humana Stock Up 0.0 %

Shares of HUM stock opened at $296.78 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market cap of $35.74 billion, a PE ratio of 26.29, a price-to-earnings-growth ratio of 2.34 and a beta of 0.52. The business’s fifty day moving average is $275.33 and its 200-day moving average is $329.47. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $504.79.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities analysts expect that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.